
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

38862548
62167
10.1038/s41598-024-62167-z
Author Correction
Author Correction: Therapeutic interventions and the length of hospital stay for pediatric patients with COVID-19: a multicenter cohort study
Ishihara Tadashi ta-shi.0517@hotmail.co.jp

1
Tagami Takashi 2
Hirayama Atsushi 3
Nakamura Yuki 1
Sueyoshi Koichiro 1
Okamoto Ken 1
Tanaka Hiroshi 1
1 grid.482669.7 0000 0004 0569 1541 Department of Emergency and Critical Care Medicine, Juntendo University, Urayasu Hospital, 2-1-1, Tomioka, Urayasu-City, Chiba 279-0021 Japan
2 https://ror.org/00krab219 grid.410821.e 0000 0001 2173 8328 Department of Emergency and Critical Care Medicine, Nippon Medical School Musashikosugi Hospital, Kawasaki-City, Kanagawa Japan
3 https://ror.org/035t8zc32 grid.136593.b 0000 0004 0373 3971 Public Health, Department of Social Medicine, Graduate School of Medicine, Osaka University, Suita-City, Osaka Japan
11 6 2024
11 6 2024
2024
14 13425© The Author(s) 2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcCorrection to: Scientific Reports 10.1038/s41598-023-48904-w, published online 05 December 2023

Atsushi Hirayama and Takashi Tagami were omitted from the author list in the original version of this Article.

The Author Contributions section now reads:

“All authors contributed to the study conception and design. T.T. and A.Y. compiled the J-RECOVER study data and provided advice on the study. Data collection and analysis were performed by T.I., Y.N. and K.S. The first draft of the manuscript was written by T.I. H.T. and K.O. provided critical review. All authors read and approved final manuscript.”

In addition, in the Results section,

“A total of 4700 COVID-19 patients with laboratory-confirmed SARS-CoV-2 infection from 62 participating hospitals were included in the main DPC study.”

now reads:

“A total of 4700 COVID-19 patients with laboratory-confirmed SARS-CoV-2 infection from 66 participating hospitals were included in the main DPC study.”

“The most commonly administered drug to pediatric patients was heparin (952.1%), followed by antimicrobial agents (847.1%).”

now reads:

“The most commonly administered drug to pediatric patients was heparin (9,52.1%), followed by antimicrobial agents (8,47.1%).”

In the Methods section, under the subheading ‘Study setting and participants’,

“This study was a sub-analysis of Japanese multicenter research on COVID-19 performed by assembling real-world data31.”

now reads:

“This study was a sub-analysis of Japanese multicenter research on COVID-19 performed by assembling real-world data (J-RECOVER study)31”.

Under the subheading, ‘DPC data’,

“A diagnosis group classification system based on the DPC was introduced in acute care hospitals in 2022, […]”

now reads:

“A diagnosis group classification system based on the DPC was introduced in acute care hospitals in 2003, […]”.

The original Article has been corrected.
